Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.
作者信息
Enos Tyler, Jeong Haneol S, Vandergriff Travis, Jacobe Heidi T, Chong Benjamin F
机构信息
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
出版信息
Dermatol Ther. 2020 Nov;33(6):e13834. doi: 10.1111/dth.13834. Epub 2020 Jul 8.
Abstract
摘要
相似文献
1
Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.经验性使用羟氯喹治疗疑似新型冠状病毒肺炎诱发急性泛发性脓疱性皮疹。
Dermatol Ther. 2020 Nov;33(6):e13834. doi: 10.1111/dth.13834. Epub 2020 Jul 8.
2
Acute generalized exanthematous pustulosis induced by hydroxychloroquine successfully treated with etretinate.羟氯喹诱导的急性泛发性脓疱性皮病用阿维A成功治疗。
J Dermatol. 2020 Feb;47(2):e53-e54. doi: 10.1111/1346-8138.15185. Epub 2019 Dec 15.
3
Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.新冠病毒病使用羟氯喹治疗后出现的急性泛发性发疹性脓疱病
Dermatol Ther. 2020 Jul;33(4):e13565. doi: 10.1111/dth.13565. Epub 2020 May 26.
4
Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.羟氯喹引发急性泛发性脓疱性皮病与史蒂文斯-约翰逊综合征重叠：一例报告
J Med Case Rep. 2020 Nov 3;14(1):210. doi: 10.1186/s13256-020-02504-8.
5
Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine.环孢素治疗羟氯喹致皮质类固醇激素耐药性急性泛发性发疹性脓疱病。
Dermatol Ther. 2018 Sep;31(5):e12660. doi: 10.1111/dth.12660. Epub 2018 Aug 28.
6
Acute generalized exanthematous pustulosis due to terbinafine.特比萘芬致急性泛发性发疹性脓疱病。
Dermatol Ther. 2018 Jul;31(4):e12617. doi: 10.1111/dth.12617. Epub 2018 May 21.
7
Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.12 例 SARS-CoV-2 阳性肺炎患者治疗中出现的急性泛发性发疹性脓疱病（AGEP）。
Am J Dermatopathol. 2021 May 1;43(5):342-348. doi: 10.1097/DAD.0000000000001819.
8
Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19).一名患有2019冠状病毒病（COVID-19）的女性因服用羟氯喹引发急性泛发性脓疱性皮病伴多形红斑样皮损
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e457-e459. doi: 10.1111/jdv.16613. Epub 2020 Jul 3.
9
Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation.羟氯喹诱导的急性泛发性脓疱性皮病：1例非典型临床表现病例
An Bras Dermatol. 2017 May-Jun;92(3):404-406. doi: 10.1590/abd1806-4841.20175561.
10
Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.用于治疗新冠肺炎的羟氯喹引发的急性泛发性脓疱性皮病
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2777-2779.e1. doi: 10.1016/j.jaip.2020.05.046. Epub 2020 Jun 7.
引用本文的文献
1
Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management.急性泛发性发疹性脓疱病：临床特征、鉴别诊断和治疗。
Am J Clin Dermatol. 2023 Jul;24(4):557-575. doi: 10.1007/s40257-023-00779-3. Epub 2023 May 8.
2
Clinical features of acute generalized exanthematous pustulosis caused by hydroxychloroquine in rheumatology patients and exploration of gene mutations.风湿科患者中由羟氯喹引起的急性泛发性脓疱性皮病的临床特征及基因突变探索
Front Med (Lausanne). 2023 Apr 6;10:1161837. doi: 10.3389/fmed.2023.1161837. eCollection 2023.
3
COVID-19 infection leading to acute pustular dermatoses.COVID-19 感染导致急性脓疱性皮肤病。
Arch Dermatol Res. 2023 May;315(4):685-697. doi: 10.1007/s00403-022-02450-z. Epub 2022 Nov 1.
4
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.新型冠状病毒肺炎患者与非新型冠状病毒肺炎患者短期口服氯喹和羟氯喹治疗的安全性：一项系统评价
Pharmaceuticals (Basel). 2022 May 21;15(5):634. doi: 10.3390/ph15050634.
5
Acute generalized exanthematous pustulosis due to hydroxichloroquine.羟氯喹所致急性泛发性发疹性脓疱病
Dermatol Ther. 2022 Jul;35(7):e15520. doi: 10.1111/dth.15520. Epub 2022 Apr 23.
6
Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.药物引发的急性泛发性脓疱性皮病（AGEP）及其临床研究：297例患者的文献病例系列
J Clin Med. 2022 Jan 13;11(2):397. doi: 10.3390/jcm11020397.
7
Severe and life-threatening COVID-19-related mucocutaneous eruptions: A systematic review.严重且危及生命的 COVID-19 相关黏膜皮肤发疹：系统回顾。
Int J Clin Pract. 2021 Dec;75(12):e14720. doi: 10.1111/ijcp.14720. Epub 2021 Sep 28.
8
A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.一项关于 COVID-19 患者治疗相关黏膜皮肤反应的系统评价。
Dermatol Ther. 2021 Jan;34(1):e14662. doi: 10.1111/dth.14662. Epub 2020 Dec 26.
本文引用的文献
1
Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019.使用氯喹和羟氯喹治疗2019冠状病毒病需谨慎。
JAMA Netw Open. 2020 Apr 24;3(4):e209035. doi: 10.1001/jamanetworkopen.2020.9035.
2
Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic review.描述羟氯喹的不良皮肤作用：一项系统综述。
J Am Acad Dermatol. 2020 Aug;83(2):563-578. doi: 10.1016/j.jaad.2020.04.024. Epub 2020 Apr 11.
3
A case of prolonged generalized exanthematous pustulosis caused by hydroxychloroquine-Literature review.一例由羟氯喹引起的迁延性泛发性脓疱性皮病——文献综述
Clin Case Rep. 2018 Oct 26;6(12):2391-2395. doi: 10.1002/ccr3.1811. eCollection 2018 Dec.
4
Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine.环孢素治疗羟氯喹致皮质类固醇激素耐药性急性泛发性发疹性脓疱病。
Dermatol Ther. 2018 Sep;31(5):e12660. doi: 10.1111/dth.12660. Epub 2018 Aug 28.
5
Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation.羟氯喹诱导的急性泛发性脓疱性皮病：1例非典型临床表现病例
An Bras Dermatol. 2017 May-Jun;92(3):404-406. doi: 10.1590/abd1806-4841.20175561.
6
7
Acute generalized exanthematous pustulosis (AGEP): A review and update.急性泛发性发疹性脓疱病（AGEP）：综述与更新。
J Am Acad Dermatol. 2015 Nov;73(5):843-8. doi: 10.1016/j.jaad.2015.07.017. Epub 2015 Sep 6.
8
Rapid clearing of acute generalized exanthematous pustulosis after administration of ciclosporin.环孢素治疗后急性泛发性发疹性脓疱病迅速消退。
Clin Exp Dermatol. 2009 Dec;34(8):e757-9. doi: 10.1111/j.1365-2230.2009.03480.x. Epub 2009 Jul 29.
9
Acute generalized exanthematous pustulosis precipitated by hydroxychloroquine.由羟氯喹引发的急性泛发性脓疱性皮病。
J Am Acad Dermatol. 2004 Apr;50(4):650-1. doi: 10.1016/s0190-9622(03)02733-6.
Zotero 插件